These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8834328)

  • 1. CEA, CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusions.
    Romero S; Fernández C; Arriero JM; Espasa A; Candela A; Martín C; Sánchez-Payá J
    Eur Respir J; 1996 Jan; 9(1):17-23. PubMed ID: 8834328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions.
    Ferrer J; Villarino MA; Encabo G; Felip E; Bermejo B; Vilà S; Orriols R
    Cancer; 1999 Oct; 86(8):1488-95. PubMed ID: 10526277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
    Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
    Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CEA and CA 549 in serum and pleural fluid of patients with pleural effusion.
    Hernández L; Espasa A; Fernández C; Candela A; Martín C; Romero S
    Lung Cancer; 2002 Apr; 36(1):83-9. PubMed ID: 11891038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of serum and pleural levels of the tumor markers CEA, CYFRA21-1 and CA 15-3 in patients with pleural effusion.
    Wagner IC; Guimarães MJ; da Silva LK; de Melo FM; Muniz MT
    J Bras Pneumol; 2007; 33(2):185-91. PubMed ID: 17724538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature.
    Shitrit D; Zingerman B; Shitrit AB; Shlomi D; Kramer MR
    Oncologist; 2005 Aug; 10(7):501-7. PubMed ID: 16079317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients.
    Villena V; López-Encuentra A; Echave-Sustaeta J; Martín-Escribano P; Ortuño-de-Solo B; Estenoz-Alfaro J
    Cancer; 1996 Aug; 78(4):736-40. PubMed ID: 8756365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleural CEA, CA-15-3, CYFRA 21-1, CA-19-9, CA-125 discriminating malignant from benign pleural effusions: Diagnostic cancer biomarkers.
    Fazli Khalaf F; Asadi Gharabaghi M; Balibegloo M; Davari H; Afshar S; Jahanbin B
    Int J Biol Markers; 2023 Jun; 38(2):81-88. PubMed ID: 36942429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions.
    Alataş F; Alataş O; Metintaş M; Colak O; Harmanci E; Demir S
    Lung Cancer; 2001 Jan; 31(1):9-16. PubMed ID: 11162861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions.
    Salama G; Miédougé M; Rouzaud P; Mauduyt MA; Pujazon MC; Vincent C; Carles P; Serre G
    Br J Cancer; 1998; 77(3):472-6. PubMed ID: 9472646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of tumor markers for differentiating malignant and benign pleural effusions of Iranian patients.
    Ghayumi SM; Mehrabi S; Doroudchi M; Ghaderi A
    Pathol Oncol Res; 2005; 11(4):236-41. PubMed ID: 16388321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma.
    Paganuzzi M; Onetto M; Marroni P; Filiberti R; Tassara E; Parodi S; Felletti R
    Chest; 2001 Apr; 119(4):1138-42. PubMed ID: 11296181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility of pleural fluid and serum markers in differentiation between malignant and non-malignant pleural effusions.
    Korczynski P; Krenke R; Safianowska A; Gorska K; Abou Chaz MB; Maskey-Warzechowska M; Kondracka A; Nasilowski J; Chazan R
    Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):128-33. PubMed ID: 20156743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of CA 549 in pleural fluid. Comparison with CEA, CA 15.3 and CA 72.4.
    Villena V; López-Encuentra A; Echave-Sustaeta J; Martín-Escribano P; Ortuño-de-Solo B; Estenoz-Alfaro J
    Lung Cancer; 2003 Jun; 40(3):289-94. PubMed ID: 12781427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of CYFRA 21-1 in malignant pleural effusion.
    Dejsomritrutai W; Senawong S; Promkiamon B
    Respirology; 2001 Sep; 6(3):213-6. PubMed ID: 11555379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of cytokeratin 19 fragment (CYFRA 21-1) as a tumor marker in malignant pleural effusion.
    Lai RS; Chen CC; Lee PC; Lu JY
    Jpn J Clin Oncol; 1999 Sep; 29(9):421-4. PubMed ID: 10563194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer.
    Lee JH; Chang JH
    Chest; 2005 Oct; 128(4):2298-303. PubMed ID: 16236887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of pleural fluid carcinoembryonic antigen and CYFRA 21-1 in patients with pleural effusion: a systematic review and meta-analysis.
    Gu P; Huang G; Chen Y; Zhu C; Yuan J; Sheng S
    J Clin Lab Anal; 2007; 21(6):398-405. PubMed ID: 18022924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor markers in pleural effusions.
    Topolcan O; Holubec L; Polivkova V; Svobodova S; Pesek M; Treska V; Safranek J; Hajek T; Bartunek L; Rousarova M; Finek J
    Anticancer Res; 2007; 27(4A):1921-4. PubMed ID: 17649796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of CEA and CA 15-3 measurements in non-purulent pleural exudates in the diagnosis of malignancy: A single-center experience.
    Porcel JM; Civit C; Esquerda A; Salud A; Bielsa S
    Arch Bronconeumol; 2017 Aug; 53(8):427-431. PubMed ID: 28237067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.